论文部分内容阅读
1.丙咪嗪和锂盐,在情感病理状态中的预防作用得到较好的实验支持.2.在混合性焦虑症和非内源性抑郁的门诊治疗中,单胺氧化酶抑制剂仍有一席之地.但三环抗抑郁剂,例如多虑平,日益证明更为有用.3.一些制药公司继续公布他们各自在苯基安定和三环抗抑郁剂类药物上的一些产品应市.4.注射用长效抗精神病制剂得到临床上普遍的欢迎和使用.口服长效制剂也有了问
1. Imipramine and lithium salts have good experimental support in the prevention of affective pathological states.2 Monoamine oxidase inhibitors still have a place in the outpatient treatment of mixed anxiety and non-endogenous depression Tricyclic antidepressants, such as doxepin, have increasingly proved to be more useful.3 Some pharmaceutical companies continue to announce that some of their respective products on phenylpropanoids and tricyclic antidepressants should be available.4. Effective antipsychotic preparations have been clinically popular and used. Oral long-acting preparations have also been asked